All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
COG / Cabot Oil & Gas Corp.
|
|
|
|
|
|
|
|
PXD / Pioneer Natural Resources Company
|
|
|
|
|
|
|
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
OMED / OptMed Inc
|
|
|
|
|
|
|
|
WMGIZ / Wright Medical Group N.V.
|
|
|
|
|
|
|
|
BIOL / BIOLASE, Inc.
|
|
|
|
|
|
|
|
ARAY / Accuray Incorporated
|
|
|
|
|
|
|
|
CLR / Continental Resources Inc (OKLA)
|
|
|
|
|
|
|
|
CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
PQ / Petroquest Energy, Inc.
|
|
|
|
|
|
|
|
TTHI / Transition Therapeutics Inc.
|
|
|
|
|
|
|
|
HNSN / Hansen Medical, Inc.
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
RPTP / Raptor Pharmaceutical Corp.
|
|
|
|
|
|
|
|
AEGR / Aegerion Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
ROKA / Roka Bioscience, Inc.
|
|
|
|
|
|
|
|
SWN / Southwestern Energy Company
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
COLL / Collegium Pharmaceutical, Inc.
|
|
|
|
|
|
|
|
PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
MDVN / Medivation, Inc.
|
|
|
|
|
|
|
|
CELGZ / Celgene Corporation Series A Contingent Value Rights
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
ECA / EnCana Corp.
|
|
|
|
|
|
|
|
GILD / Gilead Sciences, Inc.
|
|
|
|
|
|
|
|
PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
NSPR / InspireMD, Inc.
|
|
|
|
|
|
|
|
EQT / EQT Corporation
|
|
|
|
|
|
|
|
AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
YTEN / Yield10 Bioscience, Inc.
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|